Expanding Contraceptive Choice: Webinar on Intrauterine Devices (IUDs)
April 24, 2018
Some 214 million women of reproductive age in developing regions who want to avoid pregnancy are not using a modern contraceptive method. Evidence suggests that expanding method choice, as well as providing better information about available methods, can improve family planning access for these girls and women.
Kate H. Rademacher, MHA is a Technical Advisor in FHI 360’s Contraceptive Technology Innovation department where she supports the development and introduction of new, long-acting contraceptives for low-resource settings. She has fifteen years of experience in family planning program design and management. Rademacher serves as the technical lead for a portfolio of work to evaluate the potential impact of the levonorgestrel intrauterine system (LNG-IUS) in several countries in sub-Saharan Africa. She works with multi-disciplinary teams that have conducted or are conducting market assessments in Kenya, Zambia and Nigeria, and she led an analysis that compared the direct service delivery costs of the LNG-IUS to other family planning methods. She has a Masters of Healthcare Administration from the Gillings School of Global Public Health at the University of North Carolina.
Laura Glish, Population Services International (PSI)
Laura Glish has been with PSI since 2010, starting in the reproductive health department in Washington, DC. She has worked at PSI/Mali from 2011-2012 and PSI/Laos 2013-2014 as a Technical Advisor. Currently, she is a Reproductive Health Technical Advisor at PSI/Washington, where she is leading a global initiative on contraceptive counseling and LNG-IUS pilot introductions. She holds a Masters of Public Health from the University of North Carolina Gillings School of Global Public Health.
Mark J. Hathaway, MD, MPH, is a board-certified OB/GYN who was on Washington Hospital Center’s OB/GYN faculty from 1997-2013 in Washington, DC. He developed and led the Community Outreach Section, the Family Planning Section, the Ryan Residency Program, and the Family Planning Fellowship. He currently serves as a Family Planning and Reproductive Health Senior Technical Advisor for MCSP/Jhpiego. Dr. Hathaway has served on several national-level work groups and committees, including the Institute of Medicine Standing Committee on Family Planning and the National Contraceptive Metrics Workgroup. He holds appointments at George Washington University as Associate Clinical Professor of Health Care Sciences. He also served on the board of directors of the National Family Planning & Reproductive Health Association and the Association of Reproductive Health Professionals. Dr. Hathaway received his medical degree from the University of Kentucky, completed OB/GYN residency training at the Washington Hospital Center and earned a Masters of Public Health degree from Johns Hopkins University.
Some 214 million women of reproductive age in developing regions who want to avoid pregnancy are not using a modern contraceptive method. Evidence suggests that expanding method choice, as well as providing better information about available methods, can improve family planning access for these girls and women.
The Advancing Partners & Communities project, in collaboration with Family Planning 2020, the Implementing Best Practices initiative, and USAID's Office of Population and Reproductive Health, hosted a webinar series to share information about various family planning methods.
The fourth webinar in this series: Intrauterine Devices (IUDs), was on Tuesday, April 24th, 2018, from 9:00–10:00 A.M. EST.
Mark Hathaway of Jhpiego; Kate Rademacher of FHI 360; and Laura Glish of PSI discussed IUDs and their in-country and programmatic experiences.
Webinars on long-acting permanent methods will be held in the coming months.
The webinar took place on Adobe Connect. A link to the webinar was distributed to all registrants prior to the webinar.
Meet the Speakers
Kate Rademacher, FHI 360
Kate H. Rademacher, MHA is a Technical Advisor in FHI 360’s Contraceptive Technology Innovation department where she supports the development and introduction of new, long-acting contraceptives for low-resource settings. She has fifteen years of experience in family planning program design and management. Rademacher serves as the technical lead for a portfolio of work to evaluate the potential impact of the levonorgestrel intrauterine system (LNG-IUS) in several countries in sub-Saharan Africa. She works with multi-disciplinary teams that have conducted or are conducting market assessments in Kenya, Zambia and Nigeria, and she led an analysis that compared the direct service delivery costs of the LNG-IUS to other family planning methods. She has a Masters of Healthcare Administration from the Gillings School of Global Public Health at the University of North Carolina.
Laura Glish, Population Services International (PSI)
Laura Glish has been with PSI since 2010, starting in the reproductive health department in Washington, DC. She has worked at PSI/Mali from 2011-2012 and PSI/Laos 2013-2014 as a Technical Advisor. Currently, she is a Reproductive Health Technical Advisor at PSI/Washington, where she is leading a global initiative on contraceptive counseling and LNG-IUS pilot introductions. She holds a Masters of Public Health from the University of North Carolina Gillings School of Global Public Health.
Mark Hathaway, Jhpiego
Mark J. Hathaway, MD, MPH, is a board-certified OB/GYN who was on Washington Hospital Center’s OB/GYN faculty from 1997-2013 in Washington, DC. He developed and led the Community Outreach Section, the Family Planning Section, the Ryan Residency Program, and the Family Planning Fellowship. He currently serves as a Family Planning and Reproductive Health Senior Technical Advisor for MCSP/Jhpiego. Dr. Hathaway has served on several national-level work groups and committees, including the Institute of Medicine Standing Committee on Family Planning and the National Contraceptive Metrics Workgroup. He holds appointments at George Washington University as Associate Clinical Professor of Health Care Sciences. He also served on the board of directors of the National Family Planning & Reproductive Health Association and the Association of Reproductive Health Professionals. Dr. Hathaway received his medical degree from the University of Kentucky, completed OB/GYN residency training at the Washington Hospital Center and earned a Masters of Public Health degree from Johns Hopkins University.